Common deficiencies in abbreviated new drug applications: part 1: Drug substance

被引：0
|
作者：
Srinivasan, Aloka [1 ]
Iser, Robert [1 ]
机构：
[1] Office of Generic Drugs, Office of Pharmaceutical Science, US Food and Drug Administration S Center for Drug Evaluation and Research, United States
来源：
Pharmaceutical Technology | 2010年 / 34卷 / 01期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：50 / 59
相关论文
共 50 条
  • [21] Drug substance production applications
    Rudd, D
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 23 : S14 - S14
  • [22] Regulatory considerations of pharmaceutical solid polymorphism in abbreviated new drug applications (ANDAs)
    Raw, AS
    Furness, MS
    Gill, DS
    Adams, RC
    Holcombe, FO
    Yu, LX
    ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (03) : 397 - 414
  • [23] Abbreviated New Drug Applications: Generic Drug User Fee Amendments Act Analysis of Application Quality Metrics
    Woo, Jason
    Luan, Jingyu
    Li, Zili
    Grosser, Stella
    Peters, John
    Chazin, Howard
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2019, 53 (05) : 696 - 700
  • [24] FDA drug approval: Chemistry review of new drug application, abbreviated new drug application, and botanical drug products
    Getahun, Zelleka
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [25] ABBREVIATED NEW DRUG APPLICATIONS - SIMPLIFYING APPLICATIONS FOR DRUGS ABOUT WHICH INFORMATION IS ALREADY AVAILABLE
    GEISMAR, L
    FDA PAPERS, 1970, 4 (10): : 9 - &
  • [26] PATTERNS OF BIOEQUIVALENCE RECOMENDATIONS AND TRENDS OF ABBREVIATED NEW DRUG APPLICATIONS APPROVAL OVER TIME
    Wittayanukorn, S.
    Babiskin, A.
    Dutcher, S.
    Pu, X.
    Hu, M.
    Zhao, L.
    Lionberger, R.
    VALUE IN HEALTH, 2016, 19 (03) : A286 - A286
  • [27] Nanotechnology and Drug Delivery Part 1: Background and Applications
    Ochekpe, Nelson A.
    Olorunfemi, Patrick O.
    Ngwuluka, Ndidi C.
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2009, 8 (03) : 265 - 274
  • [28] Schizophrenia: New Drug Substance?
    不详
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2020, 145 (12)
  • [29] The Degradation Chemistry of Prasugrel Hydrochloride: Part 1-Drug Substance
    Baertschi, Steven W.
    Maxwell-Backer, Lindsay
    Clemens, Matthew
    Smitka, Tim A.
    Draper, Jerry R.
    Taylor, K. Wayne
    Kaerner, Andreas
    Jansen, Patrick J.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 108 (09) : 2842 - 2857
  • [30] Labeling issues for recently approved abbreviated new drug applications for extended-release products
    Gray, VA
    Rippere, RA
    PHARMACOPEIAL FORUM, 1996, 22 (01): : 1942 - 1942
12345